Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19

Lerner, R. K., Lotan, D., Oren, D., Itelman, E., Neeman, Y., Dekel, S., Heller, E., Abu-Much, A., Shilo, N., Gilead, R., Hubara, E., Mouallem, M., Haviv, Y., Kogan, A., Mayan, H., & Pessach, I. M. (2022). Prevalence and clinical implication of thrombocytopenia and heparin-induced thrombocytopenia in patients who are critically ill with COVID-19. Clinical Medicine, 22(5), 403–408. https://doi.org/10.7861/clinmed.2022-0054
Authors:
Reut Kassif Lerner
Dor Lotan
Daniel Oren
Edward Itelman
Yuval Ne’eman
Shahar Dekel
Eyal Heller
Arsalan Abu‐Much
Noya Shilo
Rami Gilead
Evyatar Hubara
Meir Mouallem
Yael Haviv
Alexander Kogan
Haim Mayan
Itai M. Pessach
Affiliated Authors:
Dor Lotan
Daniel Oren
Columbia Affiliation:
Subjects:
COVID-19 (MeSH)
Venous Thromboembolism (MeSH)
Thrombocytopenia (MeSH)
Heparin-Induced Thrombocytopenia and Thrombosis (OpenAlex Topic)
Prevention and Treatment of Venous Thromboembolism (OpenAlex Topic)
Intramuscular Injection Techniques and Complications (OpenAlex Topic)
Author Keywords:
thrombocytopenia
hit
ecmo
covid-19
elink
Publication Type:
Article
Unique ID:
10.7861/clinmed.2022-0054
PMID:
38589060
DOI:
10.7861/clinmed.2022-0054
Journal:
Clinical Medicine
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Scopus Record
View Web of Science Record

Record Created: